The Medical Billing Engagement You Are Not Qualified to Run
You are a Certified Business Intermediary whose practice is almost entirely Main Street restaurants, retail, and auto repair shops with transaction values between $250,000 and $1.2 million. A long-time client, a physician, asks you to handle the sale of a 60% controlling interest in a medical billing company: $12 million in revenue, 140 employees, an ESOP holding the remaining 40%, an open CMS compliance audit covering 2019–2021 claims, and a strategic buyer that insists on a stock purchase with full representations and warranties and a $2 million escrow. The client wants the process run within 90 days. Your state requires 12 hours of continuing education every two years; you have logged 4 hours since your last renewal, 14 months ago. You have never worked with an ESOP, a stock sale, or a healthcare compliance audit. The client has been quoted $180,000 by a regional M&A advisory firm and wants you to do it for a 4% success fee.
1. Can you accept this engagement as scoped? Analyze competence, the ESOP, and the compliance exposure.
Read the worked answer
No - not as scoped, and the reason is not modesty.
Competence is an ethical obligation, not a marketing position. Accepting work outside your competence without disclosing that and without securing the expertise is a breach of the duty of care and, in most codes of ethics, a standalone violation. The specific gaps here are not marginal: a stock sale with representations, warranties, and a $2 million escrow is a securities-adjacent transaction with tax elections, indemnification mechanics, and surviving liabilities. A 60/40 deal with an ESOP trustee triggers ERISA fiduciary duties, an independent appraisal requirement, and a trustee who will not accept a broker's opinion of value. An open CMS audit means successor liability for overpayment exposure, potential False Claims Act issues, and change-of-ownership obligations with CMS and Medicare administrative contractors. None of that is learnable in the ten days before the engagement letter is due.
The 90-day timeline is the tell. Real processes of this size take six to nine months including diligence and regulatory steps. A 90-day demand usually means the client is anchoring on the lowest-cost provider and hoping the complexity is smaller than it looks.
The fee comparison is a trap, not a benchmark. The $180,000 quote reflects scope you are not currently able to deliver. Quoting 4% ($480,000 on a $12 million enterprise, or on the 60% interest depending on structure) undercuts a firm that is doing ESOP, healthcare-regulatory, and stock-sale work and prices that risk in.
What you can accept: a defined role - for example, buyer identification and process management - under a co-engagement with an M&A firm and healthcare counsel, with your fee proportionate to your scope. Say that out loud to the client, in writing, including the specific sentence 'I have not previously handled an ESOP transaction or a stock sale of this type.'
2. If the client still wants you involved, what should the engagement structure look like and who needs to be at the table?
Read the worked answer
Build a team and a written scope - do not improvise one.
Required parties:
- ESOP trustee's independent appraiser and ERISA counsel. The trustee is a fiduciary for the 40% and cannot rely on the seller's broker. The trustee will appoint its own valuation firm; your job is to deliver a clean, defensible information package, not to advocate a number to the trustee.
- Healthcare regulatory counsel to scope the CMS audit exposure, review the change-of-ownership filing obligations, and advise on successor liability and any corporate integrity agreement history.
- M&A counsel for the seller, drafting and negotiating the stock purchase agreement, escrow, and reps and warranties.
- A tax advisor on the stock vs. asset decision and on the ESOP's own tax consequences.
- An M&A intermediary or investment bank with healthcare IT or RCM transaction experience, engaged as co-broker or as lead with you in a defined support role.
Your written scope should list what you do not do: no opinion of value for the ESOP, no legal or tax advice, no regulatory advice, no certification of historical financials. Fee should be split and disclosed - a co-brokerage agreement identifying who is paid by whom and for what, with the client's written acknowledgment.
Disclose in writing: your relevant experience, your prior deal size range, the specific elements of this transaction you have not handled, and the fact that other professionals are being retained precisely because of that. A client who knows the limits and engages you anyway is making an informed choice; a client who finds out at closing is a claim.
Realistic timeline: 6–9 months, with the CMS audit outcome and the ESOP trustee's valuation as the two gates you do not control.
3. What is your obligation on continuing education, and how does the answer change if you take the engagement?
Read the worked answer
The obligation is separate from the deal and already overdue. You are 14 months into a two-year cycle with 4 of 12 hours logged. That is not a technicality to be tidied up after closing - CBI and state renewal requirements usually include attestation that the hours were completed within the cycle, and signing an attestation that is inaccurate is a misrepresentation to the certifying body. Rectify it now: complete the remaining 8 hours within the current cycle, keep certificates, and log them before any renewal form is signed.
Prioritize the hours toward the gap. Not all 8 hours should be restaurant SDE. Ethics, transaction structure, and financial analysis hours are generally available and directly relevant. ESOP and healthcare compliance are unlikely to be covered in a general business brokerage CE catalog - which is itself the signal that you should not be the lead on those pieces.
How the answer changes if you accept:
- None of the CE hours make you competent in ESOP, stock sales, or CMS audits. Continuing education maintains competence; it does not manufacture it. Do not use a certificate as cover for scope you should not be taking.
- Accepting a $12 million, multi-professional engagement while out of compliance on a renewal requirement raises the profile of everything else. A regulator or a plaintiff's expert looking at the file will find the CE gap and use it to argue a pattern of shortcuts.
- If you take a defined co-brokerage role, document the scope, the co-broker's credentials, and the client's informed consent - and finish the CE before, not after, the engagement letter is signed.
The honest framing: the CE shortfall is a compliance housekeeping matter with a clear fix. The competence gap is the real issue, and more courses will not close it before this transaction needs to close.